Chromosome instability in diffuse large B cell lymphomas is suppressed by activation of the noncanonical NF-κB pathway

International Journal of Cancer

Volumn 136, Issue 10, 2015, Pages 2341-2351

  Ramachandiran, Sampath ^a   Adon, Arsene ^a   Guo, Xiangxue ^a   Wang, Yi ^a   Wang, Huichen ^a   Chen, Zhengjia ^b   Kowalski, Jeanne ^b   Sunay, Ustun R ^a   Young, Andrew N ^a   Brown, Theresa ^c   Mar, Jessica C ^d   Du, Yuhong ^a   Fu, Haian ^a   Mann, Karen P ^a   Natkunam, Yasodha ^e   Boise, Lawrence H ^a   Saavedra, Harold I ^a   Lossos, Izidore S ^f   Bernal Mizrachi, Leon ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c Empire Genomics LLC   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MIAMI   (United States)

Author keywords

chromosome stability; diffuse large cell lymphoma; NF B

Indexed keywords

CYCLIN G2; DNA DAMAGE INDUCIBLE 45 ALPHA PROTEIN; DNA DAMAGE INDUCIBLE TRANSCRIPT 4 PROTEIN; DOXORUBICIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CCNG2 PROTEIN, HUMAN; CELL CYCLE PROTEIN; DDIT4 PROTEIN, HUMAN; GADD45A PROTEIN, HUMAN; NUCLEAR PROTEIN;

ANAPHASE; ARTICLE; BINDING SITE; CENTROSOME; CENTROSOME AMPLIFICATION; CENTROSOME DUPLICATION; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; DNA DAMAGE; DNA REPAIR; GENOME; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; LYMPHOMA CELL; MITOSIS SPINDLE; MULTIPOLAR SPINDLE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; CELL NUCLEUS; DRUG EFFECTS; GENETICS; HUMAN CHROMOSOME; KARYOTYPE; METABOLISM; MOLECULAR GENETICS; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL NUCLEUS; CENTROSOME; CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN; CYCLIN G2; DNA DAMAGE; DNA REPAIR; DOXORUBICIN; HUMANS; KARYOTYPE; LYMPHOMA, LARGE B-CELL, DIFFUSE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84924308669     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29301     Document Type: Article

References (50)

1. Altekruse SF, Kosary CL, Krapcho M, et al. SEER Cancer Statistics Review 1975-2007. SEER web site, National Cancer Institute 2010.
2. Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2009. CA Cancer J Clin 2009; 59: 225-49.
3. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-11.
4. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 1937-47.
5. Lenz G, Nagel I, Siebert R, et al. Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma. J Exp Med 2007; 204: 633-43.
6. Staudt LM,. Oncogenic activation of NF-κB. Cold Spring Harbor Perspect Biol 2010; 2.
7. Compagno M, Lim WK, Grunn A, et al. Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma. Nature 2009; 459: 717-21.
8. Ngo VN, Young RM, Schmitz R, et al. Oncogenically active MYD88 mutations in human lymphoma. Nature 2011; 470: 115-19.
9. Lohr JG, Stojanov P, Lawrence MS, et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci USA 2012; 109: 3879-84.
10. Wu Z-H, Shi Y, Tibbetts RS, et al. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 2006; 311: 1141-46.
11. 2 by directing its kinase activity toward IκBα. Mol Cell 2012; 47: 111-21.
12. Verkoczy L, Aït-Azzouzene D, Skog P, et al. Role for nuclear factor Kappa B/Rel transcription factors in the regulation of the recombinase activator genes. Immunity 2005; 22: 519-31.
13. Derudder E, Cadera EJ, Vahl JC, et al. Development of immunoglobulin [lambda]-chain-positive B cells, but not editing of immunoglobulin [kappa]-chain, depends on NF-[kappa]B signals. Nat Immunol 2009; 10: 647-54.
14. Bhattacharya D, Lee DU, Sha WC,. Regulation of Ig class switch recombination by NF-kaapaB: retroviral expression of RelB in activated B cells inhibits switching to IgG1, but not to IgE. Int Immunol 2002; 14: 983-91.
15. Chen K, Coonrod Emily M, Kumánovics A, et al. Germline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiency. Am J Hum Genet 2013; 93: 812-24.
16. Tucker E, O'Donnell K, Fuchsberger M, et al. A novel mutation in the Nfkb2 gene generates an NF-κB2 "Super Repressor". J Immunol 2007; 179: 7514-22.
17. Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001; 412: 341-46.
18. de Miranda NF, Peng R, Georgiou K, et al. DNA repair genes are selectively mutated in diffuse large B cell lymphomas. J Exp Med 2013; 210: 1729-42.
19. Bernal-Mizrachi L, Lovly CM, Ratner L,. The role of NF-{kappa}B-1 and NF-{kappa}B-2-mediated resistance to apoptosis in lymphomas. PNAS 2006; 103: 9220-25.
20. Godar S, Ince TA, Bell GW, et al. Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression. Cell 2008; 134: 62-73.
21. Bolstad BM, Irizarry RA, Ãstrand M, et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19: 185-93.
22. Smith G,. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3:Article 3.
23. Gentleman R, Carey V, Bates D, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004; 5: R80.
24. Benjamini Y, Hochberg Y,. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 1995; 57: 289-300.
25. Culhane A, Thioulouse J, Perriere G, et al. MADE4: an R package for multivariate analysis of gene expression data. Bioinformatics 2005; 21: 2789-90.
26. Pfaffl M,. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: 2003-7.
27. Mukhopadhyay A, Deplancke B, Walhout AJM, et al. Chromatin immunoprecipitation (ChIP) coupled to detection by quantitative real-time PCR to study transcription factor binding to DNA in Caenorhabditis elegans. Nat Protoc 2008; 3: 698-709.
28. Sarosiek KA, Malumbres R, Nechushtan H, et al. Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas. Blood 2010; 115: 570-80.
29. Davis RE, Brown KD, Siebenlist U, et al. Constitutive nuclear factor {kappa}B activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 2001; 194: 1861-74.
30. Prajapati S, Yamamoto Y, Gaynor RB, et al. IKKalpha regulates the mitotic phase of the cell cycle by modulating Aurora A phosphorylation. Cell Cycle 2006; 5: 2371-80.
31. Yu Y, Zhu W, Diao H, Zhou C, et al. A comparative study of using comet assay and γH2AX foci formation in the detection of N-methyl-N-nitro-N-nitrosoguanidine-induced DNA damage. Toxicol in Vitro 2006; 20: 959-65.
32. Bhatia K, Goldschmidts W, Gutierrez M, et al. Hemi- or homozygosity: a requirement for some but not other p53 mutant proteins to accumulate and exert a pathogenetic effect. FASEB J 1993; 7: 951-6.
33. Schumm K, Rocha S, Caamano J, et al. Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit. Embo J 2006; 25: 4820-32.
34. Barré B, Coqueret O, Perkins ND,. Regulation of activity and function of the p52 NF-κB subunit following DNA damage. Cell Cycle 2010; 9: 4795-804.
35. Liebermann D, Hoffman B,. Gadd45 in stress signaling. J Mol Signal 2008; 3: 15.
36. Hollander M, Fornace AJ,. Genomic instability, centrosome amplification, cell cycle check points and Gadd45a. Oncogene 2002; 21: 6228-33.
37. Bennin DA, Don ASA, Brake T, et al. Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest. J Biol Chem 2002; 277: 27449-67.
38. Arachchige Don A, Dallapiazza R, Bennin D, et al. Cyclin G2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces a p53-dependent cell cycle arrest. Exp Cell Res 2006; 312: 4181-204.
39. Ellisen LW, Ramsayer KD, Johannessen CM, et al. REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell 2002; 10: 995-1005.
40. Schneider A, Younis RH, Gutkind JS,. Hypoxia-induced energy stress inhibits the mTOR pathway by activating an AMPK/REDD1 signaling axis in head and neck squamous cell carcinoma. Neoplasia 2008; 10: 1295-302.
41. Taylor AM, Metcalfe JA, Thick J, et al. Leukemia and lymphoma in ataxia telangiectasia. Blood 1996; 87: 423-38.
42. Jung M, Dritschilo A,. NF-κB signaling pathway as a target for human tumor radiosensitization. Semin Radiat Oncol 2001; 11: 346-51.
43. Jung M, Zhang Y, Lee S, et al. Correction of radiation sensitivity in Ataxia Telangiectasia cells by a truncated IκB-α. Science 1995; 268: 1619-21.
44. Kamsler A, Daily D, Hochman A, et al. Increased oxidative stress in Ataxia Telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res 2001; 61: 1849-54.
45. Bakhoum SF, Danilova OV, Kaur P, et al. Chromosomal instability substantiates poor prognosis in patients with diffuse large B-cell lymphoma. Clin Cancer Res 2011; 17: 7704-11.
46. van Gent DC, Hoeijmakers JHJ, Kanaar R,. Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet 2001; 2: 196-206.
47. Bunz F, Dutriaux A, Lengauer C, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282: 1497-501.
48. Chen Z, Xiao Z, Chen J, Ng S-C, et al. Human Chk1 expression is dispensable for somatic cell death and critical for sustaining G2 DNA damage checkpoint. Mol Cancer Ther 2003; 2: 543-48.
49. Igor BR, Eugenia VB, Bey-Dih C,. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 2001; 4: 303-13.
50. Castedo M, Perfettini J-L, Roumier T, et al. Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004; 23: 2825-37.